Kabvie 10 Tablet contains Vonoprazan 10 mg, a novel potassium-competitive acid blocker (P-CAB) indicated for the treatment of acid-related gastrointestinal disorders. Vonoprazan acts by selectively and reversibly inhibiting the H+/K+-ATPase enzyme in gastric parietal cells, leading to potent and sustained suppression of gastric acid secretion. Kabvie 10 is primarily prescribed for conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and eradication of Helicobacter pylori infection when used in combination with appropriate antibiotics. Its rapid onset of action and prolonged acid suppression make it advantageous over traditional proton pump inhibitors (PPIs), especially in patients with refractory symptoms or those requiring consistent acid control. The recommended dosage should be adhered to as per the prescribing physician’s guidance, typically administered once daily before meals. Kabvie 10 is generally well-tolerated; however, potential adverse effects may include headache, diarrhea, and abdominal discomfort. Caution is advised in patients with hepatic impairment, and drug interactions should be monitored, particularly with medications metabolized via cytochrome P450 enzymes. Regular clinical evaluation is recommended to assess therapeutic efficacy and monitor for any adverse reactions. Kabvie 10 Tablet should be stored in a cool, dry place away from direct sunlight and kept out of reach of children.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.